Santa Clara, Calif. -- OptiMedica, a Santa Clara-based developer of medical devices that treat ophthalmic disorders, said on Wednesday that it has raised $13.8 million in new funding, co-led by Kleiner Perkins Caufield & Byers and Alloy Ventures. David Mordaunt, the CEO of OptiMedica, said that the financing will allow the two-year-old company to roll-out new technologies. OptiMedica makes medical devices that treat disorders such as diabetic retinopathy, age-related macular degeneration, retinal vascular occlusive disease and retinal tears and detachments.
http://www.optimedica.com/
http://biz.yahoo.com/bw/060426/20060426005391.html?.v=1